Glucagon-like peptide-1
US$ 24.08
clean-label protein for glp-1 compliant food lines companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels GLP-1 use and protein demand
Description
Key Features
My GP was very direct with me: You need to lose weight, or there will be serious consequences.
The pathogenesis of NASH is complex and multifactorial, obesity and type 2 diabetes mellitus (T2DM) have been implicated as major risk factors
A limited exception to market exclusivity exists for drugs on the FDAs shortage list, which indicates a drug in low supply
Products are supported by batch-level testing using HPLC and mass spectrometry to confirm identity and purity
Just science-based answers you can trust
